#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses [...]
How to Better Predict Potential Drug Interactions Early in the Discovery Process
Dr. Jack Vanden Heuvel answers questions about the prediction of drug-drug interactions using in vitro assays and gene expression studies.
How to Better Predict Potential Drug Interactions Early in the Discovery Process
Join our webinar to discover effective strategies for early prediction of drug-drug interactions using in-vitro assays and gene expression studies.
Save Time and Money When Prioritizing Drug Candidates: Using Cell-Based Reporter Assays for Nuclear Receptor Profiling
Dr. Jack Vanden Heuvel discusses the use of cell-based reporter assays for nuclear receptor profiling to efficiently prioritize drug candidates and minimize off-target effects.
Featured Webinars
Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials
Tuesday, April 30, 2024
Sponsor: Volition
Partner: Scientist.com
Mapping Heterogeneous Interfaces Using Single-Entity Electrochemical Microspectroscopy
Thursday, April 25, 2024
Sponsors: Harvard Bioscience, Inc., HEKA Elektronik GmbH
Photoacoustic Imaging in Angiotensin II Induced Cardiac Hypertrophy Mice
Wednesday, April 17, 2024
Webinar Host: FUJIFILM VisualSonics Inc.
Advertisement
